Assessment of myocardial injury after immunotherapy in patients with cancer using multi-mode cardiac magnetic resonance (CMR)

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100041797

Enrollment

Unknown

Registered

2021-01-05

Start date

2021-02-01

Completion date

Unknown

Last updated

2021-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myocardial injury

Interventions

case series:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with cancer receiving immune checkpoint inhibitors in Union Hospital.

Exclusion criteria

Exclusion criteria: 1) Renal insufficiency (EGFR < 30 ml / min / 1.73 m ^ 2); 2) any contraindications related to MRI, such as metal foreign bodies with pacemaker, artificial metal heart valve, insulin pump, claustrophobia, gadolinium contrast agent allergy, etc.; 3) pregnant women; 4) aged < 18 years;

Design outcomes

Primary

Measure	Time frame
cardiac function;myocardial strain;late gadolinium enhancement;extracellur volume;T1 value;	—

Secondary

Measure	Time frame
myocardial enzyme;major adverse cardiovascular events;	—

Countries

China

Contacts

Public ContactHeshui Shi

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

heshuishi@hust.edu.cn+86 13871089008

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026